Search results for "Anticoagulation"

Results 1 - 10 of about 213 for "Anticoagulation".
Sort by: Relevance | Newest | Oldest

Patients with provoked VTE often on anticoagulation longer than recommended

Three variables were associated with receiving anticoagulation for longer than three months after a provoked venous thromboembolism (VTE): direct oral anticoagulant use, history of VTE, and history of myocardial infarction.
1 Nov 2022

Risks and benefits of procedure versus medication in afib vary by individual

A modeling study found that left atrial appendage occlusion could be an alternative to oral anticoagulants in patients at high bleeding risk but that the combination of risks for stroke and bleeding should be considered on an individual basis.
16 Aug 2022

Non-vitamin K oral anticoagulants appear superior to vitamin K antagonists in early-stage CKD

An accompanying editorial said that the current review supports a superior benefit profile of non-vitamin K oral anticoagulants (NOACs) in patients with atrial fibrillation and early-stage chronic kidney disease (CKD).
16 Jul 2019

Apixaban associated with lower risk of GI bleeding compared to other DOACs

Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
1 Nov 2022

Long-term anticoagulation after first unprovoked VTE associated with considerable bleeding risk

Results from a systematic review and meta-analysis provide a framework for clinicians and patients to balance the benefits and harms of extended anticoagulation for unprovoked venous thromboembolism (VTE).
14 Sep 2021

Patients with atrial fibrillation likely to underestimate bleeding risks of anticoagulants

Women were significantly less likely than men to underestimate their bleeding risk, and a history of bleeding was associated with a threefold increased likelihood of inaccurate perception of bleeding risk, according to a study of atrial fibrillation patients.
24 Aug 2021

AHA scientific statement offers guidance on LV thrombus

Among other recommendations, clinicians should treat patients with left ventricular (LV) thrombus after myocardial infarction using oral anticoagulants for three months, the American Heart Association (AHA) said.
20 Sep 2022

Intervention targeting clinicians did not increase anticoagulation use in patients with afib

Electronic messaging and academic detailing improved clinicians' comfort with prescribing anticoagulation in certain situations, but rates of appropriate anticoagulation for atrial fibrillation did not change significantly, a trial found.
25 Feb 2020

Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research

Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and a study attributed differences in men's and women's outcomes to T cells.
1 Sep 2020

Anticoagulation not superior to placebo for calf DVT in low-risk patients, may increase bleeding risk

The randomized, double-blind, placebo-controlled trial examined a composite measure of extension of calf deep venous thrombosis (DVT) to proximal veins, contralateral proximal DVT, and symptomatic pulmonary embolism in a modified intention-to-treat population.
22 Nov 2016

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next